Literature DB >> 30807338

Acute Management of Hypertension Following Intracerebral Hemorrhage.

J Tyler Haller1, Adam L Wiss, Casey C May, G Morgan Jones, Keaton S Smetana.   

Abstract

Intracerebral hemorrhage (ICH) is responsible for approximately 15% of strokes annually in the United States, with nearly 1 in 3 of these patients dying without ever leaving the hospital. Because this disproportionate mortality risk has been stagnant for nearly 3 decades, a main area of research has been focused on the optimal strategies to reduce mortality and improve functional outcomes. The acute hypertensive response following ICH has been shown to facilitate ICH expansion and is a strong predictor of mortality. Rapidly reducing blood pressure was once thought to induce cerebral ischemia, though has been found to be safe in certain patient populations. Clinicians must work quickly to determine whether specific patient populations may benefit from acute lowering of systolic blood pressure (SBP) following ICH. This review provides nurses with a summary of the available literature on blood pressure control following ICH. It focuses on intravenous and oral antihypertensive medications available in the United States that may be utilized to acutely lower SBP, as well as medications outside of the antihypertensive class used during the acute setting that may reduce SBP.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30807338     DOI: 10.1097/CNQ.0000000000000247

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  6 in total

1.  Clemastine promotes recovery of neural function and suppresses neuronal apoptosis by restoring balance of pro-inflammatory mediators in an experimental model of intracerebral hemorrhage.

Authors:  Cheng Zhi; Shulian Zeng; Yuan Chen; Degui Liao; Miaoling Lai; Zhaotao Wang; Yezhong Wang; Shiyin Xiao
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

2.  Scalp Acupuncture Protects Against Neuronal Ferroptosis by Activating The p62-Keap1-Nrf2 Pathway in Rat Models of Intracranial Haemorrhage.

Authors:  Ming-Yue Li; Xiao-Hong Dai; Xue-Ping Yu; Wei Zou; Wei Teng; Peng Liu; Xin-Yang Yu; Qi An; Xin Wen
Journal:  J Mol Neurosci       Date:  2021-08-17       Impact factor: 3.444

3.  Observation on the Effect of Solution-Focused Approach Combined with Family Involvement in WeChat Platform Management on Inpatients with Intracerebral Hemorrhage.

Authors:  Yu Song
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

4.  Epidemiology of intracerebral hemorrhage: A systematic review and meta-analysis.

Authors:  Sai Wang; Xue-Lun Zou; Lian-Xu Wu; Hui-Fang Zhou; Linxiao Xiao; Tianxing Yao; Yupeng Zhang; Junyi Ma; Yi Zeng; Le Zhang
Journal:  Front Neurol       Date:  2022-09-16       Impact factor: 4.086

5.  Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage.

Authors:  Manuel Navarro-Oviedo; Roberto Muñoz-Arrondo; Beatriz Zandio; Juan Marta-Enguita; Anna Bonaterra-Pastra; Jose Antonio Rodríguez; Carmen Roncal; Jose A Páramo; Estefania Toledo; Joan Montaner; Mar Hernández-Guillamon; Josune Orbe
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.996

6.  CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage.

Authors:  Manuel Navarro-Oviedo; Juan Marta-Enguita; Carmen Roncal; Jose A Rodríguez; Beatriz Zandio; Ramón Lecumberri; Jose Hermida; Julen Oyarzabal; Antonio Pineda-Lucena; Jose A Páramo; Roberto Muñoz; Josune Orbe
Journal:  Thromb Haemost       Date:  2022-02-03       Impact factor: 6.681

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.